Posted on

Gilead Sciences pledges support of HIV/AIDS Advocacy Programming at the Museum

California-based biopharmaceutical company Gilead Sciences has contributed to support HIV/AIDS Advocacy related program at the Museum this December.

Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. They are the manufacturer of TRUVADA, the pre-exposure prophylaxis (PrEP) drug used to help reduce the risk of HIV-1 infection.

This is Gilead’s second major gift to the Museum this year. Gilead has supported previous HIV/AIDS advocacy related programming, including The Screening Room, and Then and Now: 35 Years of HIV/AIDS, and was the first sponsor to pledge support for the Museum’s forthcoming Gender Transition exhibit. 

Published by

IMSS

The International Museum of Surgical Science, a division of the International College of Surgeons (ICS), maintains over 10,000 square feet of public galleries committed to the history of surgery, and an exquisite permanent collection of art and artifacts from the history of Medicine. The Museum supports its Mission through medically thematized exhibitions and programs, in addition to a strong contemporary art exhibition program. The Mission of the Museum is to enrich people’s lives by enhancing their appreciation and understanding of the history, development, and advances in surgery and related subjects in health and medicine. In support of this, we are committed to: -Portraying through exhibits and other appropriate media, the art and science of surgery, and related subjects. -Providing programs and services for the education and enjoyment of the public, students, and the medical profession. -Preserving our collection for the education, inspiration, and aesthetic enrichment of future generations. -Gaining recognition as a leader among medical and health museums worldwide.

Categories News, Our 2017 SponsorsLeave a comment

Leave a Reply